- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/82 - AmidesImides in position 3
Patent holdings for IPC class C07D 213/82
Total number of patents in this class: 1067
10-year publication summary
|
93
|
90
|
70
|
68
|
52
|
63
|
50
|
58
|
62
|
41
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4849 |
25 |
| Takeda Pharmaceutical Company Limited | 2710 |
25 |
| F. Hoffmann-La Roche AG | 7948 |
21 |
| Novartis AG | 10721 |
19 |
| Boehringer Ingelheim International GmbH | 4640 |
19 |
| Vertex Pharmaceuticals Incorporated | 1626 |
19 |
| Syngenta Participations AG | 1833 |
18 |
| Amgen Inc. | 4108 |
17 |
| The Johns Hopkins University | 5714 |
16 |
| BASF SE | 21017 |
14 |
| Janssen Pharmaceutica N.V. | 3367 |
13 |
| Genentech, Inc. | 4009 |
11 |
| Syngenta Crop Protection AG | 6128 |
11 |
| Bayer Cropscience AG | 2014 |
11 |
| AstraZeneca AB | 2886 |
10 |
| Sumitomo Chemical Company, Limited | 9079 |
9 |
| Mitsui Chemicals Crop & Life Solutions,Inc. | 163 |
9 |
| The General Hospital Corporation | 4770 |
8 |
| Astellas Pharma Inc. | 1087 |
8 |
| Daiichi Sankyo Company, Limited | 1877 |
8 |
| Other owners | 776 |